» Articles » PMID: 28040510

Du-Huo-Ji-Sheng-Tang and Its Active Component Ligusticum Chuanxiong Promote Osteogenic Differentiation and Decrease the Aging Process of Human Mesenchymal Stem Cells

Overview
Date 2017 Jan 2
PMID 28040510
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Ethnopharmacological Relevance: Postmenopausal osteoporosis is the most common bone disease worldwide. Information concerning the effects of herbal medicines on mesenchymal cell osteogenesis and senescence remains lacking.

Aim Of This Study: This study was designed to investigate the effects of Du-Huo-Ji-Sheng-Tang (DHJST), a Chinese herbal medicine and its active component Ligusticum chuanxiong on osteogenic differentiation and the aging process of human mesenchymal cells (hMSCs).

Materials & Methods: hMSCs were used as in vitro model and osteogenesis was induced by administration of either osteogenesis inducing medium (OIM) or dexamethasone-depleted OIM (DDOIM) for 1-week or 2 weeks and the results were evaluated by measuring the formation of mineralization nodules. The effects of the compound recipe DHJST and its active component L. chuanxiong on hMSCs osteogenesis-related gene expression was determined by real-time PCR that targeted bone morphogenetic protein-2 (BMP2), RUNX2, ALP, COL-1, osteopontin (OPN), and osteocalcin (OCN). Antibodies against BMP-related signaling pathway proteins, such as BMP-2, ERK, SMAD 1/5/8, and RUNX2, were also detected at the protein level by Western blotting. Finally, the cumulative growth curve and senescence of the hMSCs were evaluated in order to assess the aging process.

Results: L. chuanxiong increased osteogenic activity in hMSCs and up-regulated BMP-2 and RUNX2 gene expression via the activation of SMAD 1/5/8 and ERK signaling. Furthermore DHJST also showed a trend towards promoting the same effects in the same system. In the absence of dexamethasone, DHJST did activate SMAD 1/5/8 and ERK signaling and hence increased RUNX2 protein expression in hMSCs. In addition, both DHJST and L. chuanxiong delayed the hMSCs aging process by decreasing cell senescence.

Conclusions: We concluded that DHJST and its active component L. chuanxiong are able to promote osteogenic activity and decrease hMSCs senescence as cells age.

Citing Articles

Targeting cellular senescence in senile osteoporosis: therapeutic potential of traditional Chinese medicine.

Zhang Y, Yu X, Zhou C, Fu K, Luo H, Wu C Front Med (Lausanne). 2023; 10:1288993.

PMID: 38076228 PMC: 10704475. DOI: 10.3389/fmed.2023.1288993.


The Potential Relevance of PnDREBs to Panax notoginseng Nitrogen Sensitiveness.

Xia P, Zhang Y, Zhang X Biochem Genet. 2023; 62(4):2631-2651.

PMID: 37999875 DOI: 10.1007/s10528-023-10567-7.


Mechanisms of action and synergetic formulas of plant-based natural compounds from traditional Chinese medicine for managing osteoporosis: a literature review.

Zhou C, Shen S, Zhang M, Luo H, Zhang Y, Wu C Front Med (Lausanne). 2023; 10:1235081.

PMID: 37700771 PMC: 10493415. DOI: 10.3389/fmed.2023.1235081.


Du Huo Ji Sheng Tang inhibits Notch1 signaling and subsequent NLRP3 activation to alleviate cartilage degradation in KOA mice.

Chen W, Zhuang Y, Peng W, Cui W, Zhang S, Wang J Chin Med. 2023; 18(1):80.

PMID: 37386638 PMC: 10311838. DOI: 10.1186/s13020-023-00784-y.


A review of Duhuo Jisheng decoction mechanisms in intervertebral disc degeneration in vitro and animal studies.

Zhou D, Song C, Mei Y, Cheng K, Liu F, Cai W J Orthop Surg Res. 2023; 18(1):436.

PMID: 37322524 PMC: 10273736. DOI: 10.1186/s13018-023-03869-4.